Press Room

1. Dave Ramdial is our July "Volunteer of the Month"

by: JDRF Canada
July 8, 2013
Dave Ramdial, TELUS Walk to Cure Diabetes, Volunteer

JDRF is an organization that relies on the dedication and support of our volunteers across Canada. We are excited to highlight Dave Ramdial of UPS Canada, who is our first JDRF Volunteer of the Month.

2. EFSD, JDRF and Novo Nordisk renew partnership for type 1 diabetes research in Europe

September 22, 2010
Novo Nordisk, partner, partnership

Stockholm, Sweden, Sept. 22, 2010 --- The European Foundation for the Study of Diabetes (EFSD), the Juvenile Diabetes Research Foundation (JDRF) and Novo Nordisk A/S announced today the renewal of their partnership to support type 1 diabetes research in Europe. The announcement was made at the European ...

3. Sanofi-aventis and JDRF Form Partnership to Improve Therapies, Work Toward Cure for Type 1 Diabetes

July 1, 2010
Sanofi-aventis, partnership, treatment

Paris, France - July 1, 2010 - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY ) and the Juvenile Diabetes Research Foundation (JDRF) announced today a unique partnership to develop therapeutic treatments for people with type 1 diabetes at different stages of the disease - both those living with the disease ...

4. JDRF Forms Partnership with Animas to Develop First-Generation Automated System for Managing Type 1 Diabetes

January 13, 2010
Animas, partner, partnership

NEW YORK January 13, 2010 - The Juvenile Diabetes Research Foundation today announced an innovative, non-exclusive partnership with Animas Corporation to develop an automated system to help people with type 1 diabetes better control their disease - the first step on the path to what would be among the ...

5. JDRF, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership

August 5, 2009
Genomics Institute of the Novartis Research Foundation, drugs, partnership

New York, NY, August 5, 2009 -- JDRF said today that it has entered into a novel collaborative research agreement with the Genomics Institute of the Novartis Research Foundation (GNF) to create a diabetes drug discovery and development platform. The four-year program is one of the largest and ...